Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Healthtrust
Deloitte
Teva
Baxter
Argus Health
Julphar
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim

Generated: February 22, 2018

DrugPatentWatch Database Preview

E.E.S. 400 Drug Profile

« Back to Dashboard

When do E.e.s. 400 patents expire, and what generic alternatives are available?

E.e.s. 400 is a drug marketed by Arbor Pharms Llc and is included in two NDAs.

The generic ingredient in E.E.S. 400 is erythromycin ethylsuccinate. There are one hundred and one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
Drug patent expirations by year for E.E.S. 400
Pharmacology for E.E.S. 400
Medical Subject Heading (MeSH) Categories for E.E.S. 400

US Patents and Regulatory Information for E.E.S. 400

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc E.E.S. 400 erythromycin ethylsuccinate SUSPENSION;ORAL 061639-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Arbor Pharms Llc E.E.S. 400 erythromycin ethylsuccinate TABLET;ORAL 061905-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Arbor Pharms Llc E.E.S. 400 erythromycin ethylsuccinate TABLET;ORAL 061905-002 Aug 12, 1982 BX RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Dow
Queensland Health
Medtronic
Moodys
Daiichi Sankyo
Healthtrust
Cerilliant
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot